CUREVAC N V's ticker is CVAC and the CUSIP is N2451R105. A total of 110 filers reported holding CUREVAC N V in Q4 2021. The put-call ratio across all filers is 1.98 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $165,189 | -46.4% | 23,700 | -39.4% | 0.00% | -33.3% |
| Q3 2022 | $308,000 | -65.7% | 39,100 | -14.5% | 0.00% | -62.5% |
| Q1 2022 | $897,000 | -84.6% | 45,756 | -57.0% | 0.01% | -86.7% |
| Q3 2021 | $5,822,000 | +131.2% | 106,498 | +211.8% | 0.06% | +122.2% |
| Q2 2021 | $2,518,000 | – | 34,152 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 3,134,780 | $107,600,000 | 32.65% |
| Affinity Asset Advisors, LLC | 50,000 | $1,716,000 | 0.62% |
| Renaissance Capital LLC | 21,659 | $743,000 | 0.19% |
| Eversept Partners, LP | 85,017 | $2,916,933 | 0.19% |
| TWINBEECH CAPITAL LP | 67,504 | $2,316,000 | 0.13% |
| Alpine Global Management, LLC | 23,033 | $790,000 | 0.12% |
| Paradigm Financial Advisors, LLC | 13,535 | $464,000 | 0.10% |
| Caption Management, LLC | 200,000 | $6,860,000 | 0.08% |
| Baillie Gifford | 3,923,340 | $134,610,000 | 0.07% |
| Donoghue Forlines LLC | 11,570 | $397,000 | 0.07% |